| dc.creator |
GÖRGÜLÜ, Ümit; SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ANKARA ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, NÖROLOJİ ANABİLİM DALI |
|
| dc.creator |
GÜRHAN, Nermin; TOKAT GAZİOSMANPAŞA ÜNİVERSİTESİ, SAĞLIK BİLİMLERİ FAKÜLTESİ, HEMŞİRELİK BÖLÜMÜ |
|
| dc.creator |
YALÇIN AKMAN, Yasemin; UNIVERSITY OF HEALTH SCIENCES, İSTANBUL FATİH SULTAN MEHMET TRAINING RESEARCH CENTER |
|
| dc.creator |
POLAT, Ülkü; GAZİ ÜNİVERSİTESİ, SAĞLIK BİLİMLERİ FAKÜLTESİ |
|
| dc.creator |
ALTAY, Kevser; SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ANKARA SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ |
|
| dc.creator |
ÖZEN, Şükrü; BİNGÖL ÜNİVERSİTESİ SAĞLIK BİLİMLERİ FAKÜLTESİ |
|
| dc.creator |
COŞAR, Behçet; GAZİ ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, PSİKİYATRİ ANABİLİM DALI |
|
| dc.creator |
KOLCU, Giray; SÜLEYMAN DEMİREL ÜNİVERSİTESİ, TIP FAKÜLTESİ, TEMEL TIP BİLİMLERİ BÖLÜMÜ |
|
| dc.date |
2022-03-01T00:00:00Z |
|
| dc.date.accessioned |
2022-05-10T10:59:01Z |
|
| dc.date.available |
2022-05-10T10:59:01Z |
|
| dc.identifier |
https://dergipark.org.tr/tr/pub/sdutfd/issue/68474/1048635 |
|
| dc.identifier |
10.17343/sdutfd.1048635 |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/96238 |
|
| dc.description |
ObjectiveThis study was conducted to determine psychiatricdiseases accompanying common neurologicaldiseases.Material and MethodsThe study is a retrospective study. The files of 1125patients diagnosed with neurologic disease who weretreated as an outpatient in the psychiatry outpatientclinic between 26.12.2016 - 26.12.2017 wereexamined.ResultsThe most commonly depression 59.9% and anxietydisorder 42.5% were diagnosed in neurology patientsreceiving outpatient treatment in the psychiatryoutpatient clinic. This anxiety was more commonin migraine (63.3 %) and depression was mostcommonly seen in multiple sclerosis (67.2%). Thecognitive impairment (11.9%), sleep disorders (10%),Alzheimer's disease (21.1%) and dementia (12.6%)were more common in Parkinson disease.ConclusionThis study supports that psychiatric disordersfrequently accompany neurological diseases.Therefore, psychiatric evaluation is required in orderto increase the quality of life in neurological diseases. |
|
| dc.description |
AmaçBu çalışma, yaygın nörolojik hastalıklara eşlik edenpsikiyatrik hastalıkları belirlemek amacıyla yapılmıştır.Gereç ve YöntemÇalışma retrospektif bir çalışmadır. 26.12.2016 -26.12.2017 tarihleri arasında psikiyatri polikliniğindeayaktan tedavi gören nörolojik hastalık tanısı olan1125 hastanın dosyaları incelendi.BulgularPsikiyatri polikliniğinde ayaktan tedavi gören nörolojihastalarında en sık depresyon (%59.9) ve anksiyetebozukluğu (%42.5) saptandı. Anksiyete bozukluğu(%63.3) migrende daha yaygındı ve depresyon ensık multiple sklerozda (%67.2) görüldü. Parkinsonhastalığında kognitif bozukluk (%11,9), uyku bozuklukları(%10), Alzheimer hastalığı (%21,1) ve demans(%12,6) daha sıktı.SonuçBu çalışma, psikiyatrik bozuklukların nörolojik hastalıklarasık eşlik ettiğini desteklemektedir. Bu nedenlenörolojik hastalıklarda yaşam kalitesini artırmak içinpsikiyatrik değerlendirilmede gerekmektedir. |
|
| dc.format |
application/pdf |
|
| dc.language |
en |
|
| dc.publisher |
Süleyman Demirel Üniversitesi |
|
| dc.publisher |
Süleyman Demirel University |
|
| dc.relation |
https://dergipark.org.tr/tr/download/article-file/2159884 |
|
| dc.source |
Volume: 29, Issue: 1
75-83 |
en-US |
| dc.source |
1300-7416 |
|
| dc.source |
2602-2109 |
|
| dc.source |
SDÜ Tıp Fakültesi Dergisi |
|
| dc.subject |
comorbidity,psychiatric disorders,neurological diseases,prevelance |
|
| dc.subject |
psikiyatrik bozukluklar,nörolojik hastalıklar,komorbid,yaygınlık |
|
| dc.title |
COMORBID PSYCHIATRIC DISORDERS IN SOME COMMON NEUROLOGICAL DISEASES |
en-US |
| dc.title |
YAYGIN BAZI NÖROLOJİK HASTALIKLARDA KOMORBİD PSİKİYATRİK BOZUKLUKLAR |
tr-TR |
| dc.type |
info:eu-repo/semantics/article |
|
| dc.citation |
1. Kulaksızoğlu IB. Nörolojik Hastalıkların Psikiyatrik Yansımaları.
http://www. itfnoroloji.org/ psikiyatrik/Psikiyatrik.htm. [Accessed
14 December 2020] |
|
| dc.citation |
2. Taj R. Mlanzoor M. Psychiatric disorders in neurology. Pak J
Neurological Sci 2014;9(3):48-50. |
|
| dc.citation |
3. Jefferies, K.; Owino, A.; Rickards, H.; Agrawal, N. Psychiatric
disorders in inpatients on a neurology ward: Estimate of prevalence
and usefulness of screening questionnaires. J. Neurol.
Neurosurg. Psychiatry 2007, 78, 414–416 |
|
| dc.citation |
4. Dale C. Hesdorffer. Comorbidity between neurological illness
and psychiatric disorders. CNS Spectrums. Neuropsychiatry
2016 Jun;21(3):230-2388 |
|
| dc.citation |
5. Jasper Nuyena,, Franc¸ois G. Schellevisa et all. Comorbidity
was associated with neurologic and psychiatric diseases: A general
practice-based controlled study. Journal of Clinical Epidemiology:
59, 2006, nr. 12, p. 1274-1284 |
|
| dc.citation |
6. Kim J, Kim Y, Bae JS, Lee JH, Song HK. Concomitant Psychiatric
Symptoms in Neurological Outpatients. Int J Environ Res
Public Health 2019;16(5):860. |
|
| dc.citation |
7. Menculini G, Chipi E, Paoletti P. E., Gaetani L, Nigro P, Simoni
S, Mancini A. et all. Insights into the Pathophysiology of Psychiatric
Symptoms in Central Nervous System Disorders: Implications
for Early athe nd Differential Diagnosis. Int J Mol Sci.
2021 Apr 23;22(9):4440 |
|
| dc.citation |
8. Bridges, K.W.; Goldberg, D.P. Psychiatric illness in inpatients
with neurological disorders: Patients’ views on discussion of
emotional problems with neurologists. Br. Med. J. (Clin. Res.
Ed.) 1984, 289, 656–658. |
|
| dc.citation |
9. Ho, R.C.; Fu, E.H.; Chua, A.N.; Cheak, A.A.; Mak, A. Clinical
and psychosocial factors associated with depression and
anxiety in Singaporean patients with rheumatoid arthritis. Int. J.
Rheum. Dis. 2011, 14, 37–47. |
|
| dc.citation |
10. Ho, R.C.; Mak, K.K.; Chua, A.N.; Ho, C.S.; Mak, A. The effect of
severity of depressive disorder on economic burden in a university
hospital in Singapore. Expert Rev. Pharm. Outcomes Res.
2013, 13, 549–559. |
|
| dc.citation |
11. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W.
Structured Clinical Interview for DSM-IV Axis I Disorders (SCID
I).1997, New York: Biometric Research Department. |
|
| dc.citation |
12. Özkürkçügil, A., Aydemir, Ö., Yıldız, M., Esen Danacı, A., &
Köroglu. DSM-IV Eksen I Bozuklukları İçin Yapılandırılmıs ̧ Klinik
Görüs ̧Menin Türkçe'ye Uyarlanması ve Güvenilirlik Çalısması.
İlaç ve Tedavi dergisi 1999;12(4): 233–236. |
|
| dc.citation |
13. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. The
struc-tured clinical interview for DSM–III–R personality disorders
(SCID–II).Part I: Description.Journal of Personality disorders,
1995;9(2), 83–91 |
|
| dc.citation |
14. CosKunol, H., BaĞgdiken,I., Sorias, S., & Saygılı, R. SCID-II
(Türkçeversiyonu) görüşmesinin kişilik bozukluklarındaki güvenirligi.
TürkPsikoloji Dergisi 1994; 9(32): 26–29 |
|
| dc.citation |
15. Carson A, Ringbauer B, MacKenzie L.et al Neurological disease,
emotional disorder, and disability: they are related: a study
of 300 consecutive new referrals to a neurology outpatient department.
J Neurol Neurosurg Psychiatry 200068202–206. |
|
| dc.citation |
16. Qing-Fei Zhao, Lan Tan, Hui-Fu et all. WangThe prevalence of
neuropsychiatric symptoms in Alzheimer's disease: Systematic
review and meta-analysis. Journal of Affective Disorders, 2016,
190: 264-271 |
|
| dc.citation |
17. Justine Orr, Charles N Bernstein, Lesley A. Graff et all. Factors
associated with perceived need for mental health care in
multiple sclerosis. Multiple Sclerosis and Related Disorders 25
(2018): 179–185 |
|
| dc.citation |
18. Peres M, Mercante J, Tobo PR, Kamei H, Bigal ME. Anxiety
and depression symptoms and migraine: a symptom-based approach
research. J Headache Pain 2017; 18(1): 37. |
|
| dc.citation |
19. Hartoonian N, Terrill AL, Beier ML, et al. Predictors of anxiety in
multiple sclerosis. Rehabil Psychol 2015; 60(1): 91–98. https://
doi.org/10.1037/rep0000019. |
|
| dc.citation |
20. Clary HMM, Snively BM, Hamberger MJ. Anxiety is common
and independently associated with clinical features of epilepsy.
Epilepsy Behav 2018;85:64–71. https://doi.org/ 10.1016/ j.ye-
beh.2018.05.024. |
|
| dc.citation |
21. Sönmez İ, Mut S, Bozkurt A. Psychiatric Symptoms and Disorders
in Multiple Sclerosis: Review. Turkiye Klinikleri J Neur.
2016;11(2):46-54. doi: 10.5336/neuro.2016-51118. |
|
| dc.citation |
22. Hanna M, Strober LB. Anxiety and depression in Multiple Sclerosis
(MS): Antecedents, consequences, and differential impact
on well-being and quality of life. Mult. Scler. Relat. Disord
2020;44:102261. Advance online publication. https://doi.org/
10.1016/ j.msard.2020.10226. |
|
| dc.citation |
23. Lubomski M, Davis RL, Sue CM. Depression in Parkinson's
disease: perspectives from an Australian cohort. J Affect
Disord 2020;277:1038-1044. https://doi.org/ 10.1016/ j.
jad.2020.09.032. |
|
| dc.citation |
24. Pekel NB, Yıldız D, Sığırlı D, Güneş A, Seferoğlu M. The Evaluation
of Depression, Anxiety Disorder and Sleep Quality in
Parkinson Disease Patients. Uludağ Üniv Tıp Fak Derg. 2017;
43(3):91-96. |
|
| dc.citation |
25. Topbaş E, Eroğlu MZ, Zabun S, Güneş T, Çalışkan M. Electroconvulsive
Therapy in a Depressive Patient with Comorbid Parkinson
Disease. Cukurova Medical Journal 2014; 39(1):185-
188. https://doi.org/10.17826/cutf.26007. |
|
| dc.citation |
26. Dindo LN, Recober A, Haddad R, Calarge CA. Comorbidity of
migraine, major depressive disorder, and generalized anxiety
disorder in adolescents and young adults. Int J Behav Med
2017; 24(4):528-534. doi: 10.1007/s12529-016-9620-5. |
|
| dc.citation |
27. Yavuz BG, Aydinlar EI, Dikmen PP, Incesu C. Association
between somatic amplification, anxiety, depression, stress and
migraine. J Headache Pain 2013;14 (1):53.doi: 10.1186/1129-
2377-14-53. |
|
| dc.citation |
28. Hung CI, Liu CY, Yang CH, Wang SJ. Migraine with active headache
was associated with other painful physical symptoms at
two-year follow-up among patients with major depressive disorder.
Plos One 2019; 14(4): e0216108. https://doi.org/ 10.1371/
journal.pone.0216108 |
|
| dc.citation |
29. Sah SK, Rai N, Sah MK, et al. Comorbid depression and its
associated factors in patients with epilepsy treated with single
and multiple drug therapy: A cross-sectional study from Himalayan
country. Epilepsy Behav 2020; 112:107455. https://doi.
org/10.1016/ j.yebeh.2020.107455 |
|
| dc.citation |
30. Kim SJ, Lee SA, Ryu HU, et al. Factors associated with obsessive-
compulsive symptoms in people with epilepsy. Epilepsy
Behav 2020; 102:106723. https://doi.org/10.1016/ j.yebeh.
2019.106723 |
|
| dc.citation |
31. Foroughipour M, Behdani F, Hebrani P, et al. Frequency of obsessive-
compulsive disorder in patients with multiple sclerosis:
A cross-sectional study. J Res Med Sci 2012;17(3), 248–253. |
|
| dc.citation |
32. Lo Monaco MR, Di Stasio E, Zuccalà G, et al. Prevalence of Obsessive-
Compulsive Symptoms in Elderly Parkinson Disease
Patients: A Case-Control Study. Am J Geriatr Psychiatry 2020;
28(2): 167–175. https:// doi.org/ 10.1016/j.jagp.2019.08.022 |
|
| dc.citation |
33. Maia AF, Pinto AS, Barbosa ER, Menezes PR, Miguel EC.
Obsessive-compulsive symptoms, obsessive-compulsive
disorder, and related disorders in Parkinson's disease. J
Neuropsychiatry Clin Neurosci 2003; 15(3): 371–374. https://
doi.org/10.1176/jnp.15.3.371 |
|
| dc.citation |
34. Goulart AC, Santos IS, Brunoni AR, et al. Migraine headaches
and mood/anxiety disorders in the ELSA Brazil. Headache
2014;54(8):1310–1319. https://doi.org/10.1111/head.12397. |
|
| dc.citation |
35. Amato MP, Prestipino E, Bellinvia A, et al. (2019). Cognitive
impairment in multiple sclerosis: An exploratory analysis
of environmental and lifestyle risk factors. Plos One, 14(10),
e0222929. https://doi.org/10.1371/journal.pone.0222929 |
|
| dc.citation |
36. Weil RS, Hsu JK, Darby RR, et al. Neuroimaging in Parkinson’s
disease dementia: connecting the dots. Brain Commun
2019;1(1):fcz006. doi: 10.1093/ braincomms/fcz006. |
|
| dc.citation |
37. Benbir G, Karadeniz G. Parkinson Hastalığında Uyku Bozuklukları.
Parkinson Hastalığı ve Hareket Bozuklukları Dergisi
2011;14(2):59-72. |
|
| dc.citation |
38. Lai YY, Hsieh KC, Nguyen D, Peever J, Siegel JM. Neurotoxic
lesions at the ventral mesopontine junction change sleep time
and muscle activity during sleep: an animal model of motor
disorders in sleep. Neuroscience 2008; 154(2):431-443. doi:
10.1016/ j. neuroscience. 2008.03.085. |
|
| dc.citation |
39. Melka D, Tafesse A, Bower JH, Assefa D. Prevalence of sleep
disorders in Parkinson's disease patients in two neurology referral
hospitals in Ethiopia. BMC Neurology 2019; 19(1):205.
https://doi.org/10.1186/s12883-019-1431-2. |
|
| dc.citation |
40. Sahebzadeh N, Baf MMF, Homam SM. Sleep Quality and Cognitive
Impairment in Patients with Parkinson’s disease in Iran.
Turk J Neurol 2016;22:121-6. doi:10.4274/tnd.84755. |
|
| dc.citation |
41. Dharmadhikari AS, Sinha VK. Psychiatric Comorbidity in Children
with Epilepsy: A Cross-sectional 5 Years Rural Prevalence
Study. J Neurosci Rural Pract 2017; 8(2); 179–184. https://doi.
org/10.4103/jnrp.jnrp_487_16. |
|
| dc.citation |
42. Chen Z, Lusicic A, O'Brien TJ, et al. Psychotic disorders induced
by antiepileptic drugs in people with epilepsy. Brain
2016;139(:2668–2678. https://doi.org/10.1093/brain/aww196. |
|
| dc.citation |
43. Holmes GL. Cognitive impairment in epilepsy: the role of
network abnormalities. Epileptic Disord 2015;17(2):101–16. https://
doi.org/10.1684/epd.2015.0739. |
|
| dc.citation |
44. Clancy MJ, Clarke MC, Connor DJ, Cannon, M, Cotter DR.
The prevalence of psychosis in epilepsy; a systematic review
and meta-analysis. BMC Psychiatry 2014; 14:75. https:// doi.
org/10.1186/1471-244X-14-75. |
|
| dc.citation |
45. Pinckaers F, Boon ME, Majoie M. Risk factors predisposing to
psychotic symptoms during levetiracetam therapy: A retrospective
study. Epilepsy behav 2019;100(Pt A):106344. https://doi.
org/10.1016/j.yebeh.2019.05.039. |
|
| dc.citation |
46. MacDonald KE, Cozza K L, Vythilingam M. Epilepsy-Related
Psychosis: A Case Report and Brief Review of Literature. Psychosomatics
2020; 61(4):400–404. https://doi.org/10.1016/
j.psym.2019.11.004. |
|
| dc.citation |
47. Dravet C.Troubles comportementaux des épileptiques [The
behavioral disorders in epilepsy]. Revue neurologique 2002;
158(5 Pt 2): 4S33–4S38. |
|
| dc.citation |
48. Salpekar J. Mood Disorders in Epilepsy Focus. Am Psychiatr
Publ 2016; 14(4): 465–72. doi: 10.1176/appi.focus.20160017 |
|
| dc.citation |
49. Alyanak B., Psychogenic Seizure, Trauma in the Developmental
Process. Arch Neuropsychiatry 2013; 50: 291-294. doi:
10.4274/npa.y6990. |
|
| dc.citation |
50. Ahmadvand A, Sepehrmanesh Z, Ghoreishi FS, Afshinmajd S.
Prevalence of psychiatric disorders in the general population of
Kashan, Iran. Arch. Iran. Med 2012;15(4): 205–209. |
|
| dc.citation |
51. McKenzie JA, Spielman LJ, Pointer CB, et al. Neuroinflammation
as a Common Mechanism Associated with the Modifiable
Risk Factors for Alzheimer's and Parkinson's Diseases.
Curr. Aging Sci 2017;10(3):158–176. https://doi.org/10.2174/
1874609810666 17031511 3244. |
|
| dc.citation |
52. Sen A, Capelli V, Husain M. Cognition and dementia in older
patients with epilepsy. Brain 2018;141(6):1592–1608. https://
doi.org/10.1093/brain/awy022. |
|
| dc.citation |
53. Subota A, Pham T, Jetté N, et al. The association between dementia
and epilepsy: A systematic review and meta-analysis. Epilepsia
2017; 58(6):962–972. https://doi.org/10.1111/ epi.13744. |
|
| dc.citation |
54. Kim GH, Kim JY, Byeon JH, et al. Attention deficit hyperactivity
disorder in epileptic children. J Korean Med Sci 2012;27(10):
1229–1232. https://doi.org/10.3346/jkms .2012.27.10.1229 |
|
| dc.citation |
55. Wang X, Lv Y, Zhang W, Meng H. Cognitive Impairment and
Personality Traits in Epilepsy: Characterization and Risk Factor
Analysis. J Nerv Ment Dis 2018; 206(10): 794–799. https:// doi.
org/10.1097/NMD.0000000000000880. |
|
| dc.citation |
56. Ayta S, Korkmaz B. Cognitive Dysfunctions in Epileptic Syndromes
Epilepsi 2014;20(Ek 1):37-45 doi: 10.5505/epilepsi.
2014.70894 |
|
| dc.citation |
57. Ashjazadeh N, Sahraeian A, Sabzgolin I, Asadi-Pooya AA.
Attention-deficit hyperactivity disorder in adults with epilepsy.
Epilepsy Behav 2019; 101(Pt A), 106543. https://doi.org/
10.1016/j.yebeh.2019.106543. |
|